FGF21 attenuates lipolysis in human adipocytes - A possible link to improved insulin sensitivity

FEBS Letters

Volumn 582, Issue 12, 2008, Pages 1725-1730

  Arner, Peter ^a   Pettersson, Amanda ^a   Mitchell, Pamela J ^b   Dunbar, James D ^b   Kharitonenkov, Alexei ^b   Rydén, Mikael ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Klotho; Adipocyte; Adipogenesis; Differentiation; Lipolysis; Perilipin

Indexed keywords

ADIPOGENIC TRANSCRIPTION FACTOR; ADIPOSE DERIVED TRIGLYCERIDE LIPASE; FATTY ACID; FIBROBLAST GROWTH FACTOR 21; GLYCEROL; INSULIN; MESSENGER RNA; PERILIPIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHODIESTERASE 3B; PROTEIN; PROTEIN KINASE A REGULATORY PROTEIN 1ALPHA;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN 3T3; CONTROLLED STUDY; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INCUBATION TIME; INSULIN SENSITIVITY; LIPOLYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; CELL DIFFERENTIATION; FATTY ACIDS; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION; GLUCURONIDASE; HUMANS; INSULIN RESISTANCE; LIPOLYSIS; MICE; PHOSPHOPROTEINS;

ANIMALIA; MURINAE;

EID: 43549110007     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2008.04.038     Document Type: Article

References (20)

1. Nishimura T., Nakatake Y., Konishi M., and Itoh N. Identification of a novel FGF, FGF-21, preferentially expressed in the liver. Biochim. Biophys. Acta 1492 (2000) 203-206
2. Kharitonenkov A., et al. FGF-21 as a novel metabolic regulator. J. Clin. Invest. 115 (2005) 1627-1635
3. Kharitonenkov A., et al. The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21. Endocrinology 148 (2007) 774-781
4. Wente W., et al. Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways. Diabetes 55 (2006) 2470-2478
5. Inagaki T., et al. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metab. 5 (2007) 415-425
6. Ogawa Y., et al. BetaKlotho is required for metabolic activity of fibroblast growth factor 21. Proc. Natl. Acad. Sci. USA 104 (2007) 7432-7437
7. Langin D., and Arner P. Importance of TNFalpha and neutral lipases in human adipose tissue lipolysis. Trends Endocrinol. Metab. 17 (2006) 314-320
8. Zhang H.H., Halbleib M., Ahmad F., Manganiello V.C., and Greenberg A.S. Tumor necrosis factor-{alpha} stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP. Diabetes 51 (2002) 2929-2935
9. Ryden M., et al. Comparative studies of the role of hormone-sensitive lipase and adipose triglyceride lipase in human fat cell lipolysis. Am. J. Physiol. Endocrinol. Metab. 292 (2007) E1847-E1855
10. Arvidsson E., Blomqvist L., and Ryden M. Depot-specific differences in perilipin mRNA but not protein expression in obesity. J. Intern. Med. 255 (2004) 595-601
11. Badman M.K., Pissios P., Kennedy A.R., Koukos G., Flier J.S., and Maratos-Flier E. Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab. 5 (2007) 426-437
12. Moyers J.S., Shiyanova T.L., Mehrbod F., Dunbar J.D., Noblitt T.W., Otto K.A., Reifel-Miller A., and Kharitonenkov A. Molecular determinants of FGF-21 activity-synergy and cross-talk with PPARgamma signaling. J. Cell Physiol. 210 (2007) 1-6
13. Wang H., Qiang L., and Farmer S.R. Identification of a domain within PPAR{gamma} regulating expression of a group of genes containing FGF21 that are selectively repressed by SIRT1 in adipocytes. Mol. Cell Biol. (2007)
14. Miyoshi H., et al. Perilipin promotes hormone-sensitive lipase-mediated adipocyte lipolysis via phosphorylation-dependent and -independent mechanisms. J. Biol. Chem. 281 (2006) 15837-15844
15. Moore H.P., Silver R.B., Mottillo E.P., Bernlohr D.A., and Granneman J.G. Perilipin targets a novel pool of lipid droplets for lipolytic attack by hormone-sensitive lipase. J. Biol. Chem. 280 (2005) 43109-43120
16. Granneman J.G., Moore H.P., Granneman R.L., Greenberg A.S., Obin M.S., and Zhu Z. Analysis of lipolytic protein trafficking and interactions in adipocytes. J. Biol. Chem. 282 (2007) 5726-5735
17. Marcinkiewicz A., Gauthier D., Garcia A., and Brasaemle D.L. The phosphorylation of serine 492 of perilipin a directs lipid droplet fragmentation and dispersion. J. Biol. Chem. 281 (2006) 11901-11909
18. Martinez-Botas J., et al. Absence of perilipin results in leanness and reverses obesity in Lepr(db/db) mice. Nat. Genet. 26 (2000) 474-479
19. Tansey J.T., et al. Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity. Proc. Natl. Acad. Sci. USA 98 (2001) 6494-6499
20. Londos C., Brasaemle D.L., Schultz C.J., Segrest J.P., and Kimmel A.R. Perilipins, ADRP, and other proteins that associate with intracellular neutral lipid droplets in animal cells. Semin. Cell Dev. Biol. 10 (1999) 51-58